Morning Free and Total Testosterone in HIV-infected Men: Implications for the Assessment of Hypogonadism

Overview

Journal AIDS Res Ther

Publisher Biomed Central

Specialty Infectious Diseases

Date 2014 Jan 24

PMID 24450960

Citations 22

Authors

Anne K Monroe

Adrian S Dobs

Frank J Palella

Lawrence A Kingsley

Mallory D Witt

Todd T Brown

Affiliations

Soon will be listed here.

Abstract

Background: Hypogonadism is common among HIV-infected men, even among men receiving antiretroviral therapy (ART). Our objective in this study was to determine the prevalence of biochemical hypogonadism among HIV-infected men compared with HIV-uninfected controls. We also examined the use of free testosterone (FT) and total testosterone (TT) measurements in the assessment of biochemical hypogonadism in HIV-infected and -uninfected men.

Methods: This was a cross-sectional analysis from the Multicenter AIDS Cohort Study (MACS). TT levels were measured from archived serum using liquid chromatography-tandem mass spectrometry. FT was calculated from TT and sex hormone-binding globulin (SHBG) (measured by radioimmunoassay) using the Vermeulen equation. Biochemical hypogonadism was defined as having low TT, low FT, or both.

Results: Of 945 men in the MACS Cardiovascular Substudy, T assays were not performed in 89 because of insufficient/no stored serum (n = 18) or use of T replacement therapy (TRT) (n = 71). 530 men had morning (AM) T measurements; 364 (68.7%) were HIV-infected. The prevalence of biochemical hypogonadism was similar in HIV-infected (34/364 = 9.3%) and HIV-uninfected (12/166 = 7.2%) men. Prevalence of hypogonadism, when men on TRT (n = 71) were included in the group of hypogonadal men, was higher in HIV-infected (104/434 = 24.0%) compared with HIV-uninfected (13/167 = 7.8%) men (p < 0.0001). Of 34 HIV-infected men with biochemical hypogonadism not on TRT, 11 (32.4%) had normal TT, but low FT. Of 12 HIV-uninfected men with biochemical hypogonadism not on TRT, none were in this category (p = 0.04) - all had low TT.

Conclusions: The prevalence of biochemical hypogonadism in our sample of HIV-infected men was approximately 10%, with a substantial proportion of these men having a normal TT, but low FT. The measurement of AM FT, rather than TT, in the assessment of hypogonadism in HIV-infected men will likely increase diagnostic sensitivity and should be recommended.

Citing Articles

The consequences of climate change and male reproductive health: A review of the possible impact and mechanisms.

Akhigbe R, Oyedokun P, Akhigbe T, Hamed M, Fidelis F, Omole A Biochem Biophys Rep. 2024; 41:101889.

PMID: 39717849 PMC: 11664087. DOI: 10.1016/j.bbrep.2024.101889.

Update on acquired hypogonadism in men living with HIV: pathogenesis, clinic, and treatment.

De Vincentis S, Rochira V Front Endocrinol (Lausanne). 2023; 14:1201696.

PMID: 37455928 PMC: 10338827. DOI: 10.3389/fendo.2023.1201696.

Role of sex hormone-binding globulin in the free hormone hypothesis and the relevance of free testosterone in androgen physiology.

Narinx N, David K, Walravens J, Vermeersch P, Claessens F, Fiers T Cell Mol Life Sci. 2022; 79(11):543.

PMID: 36205798 PMC: 11803068. DOI: 10.1007/s00018-022-04562-1.

Qrareya A, Mahdi F, Kaufman M, Ashpole N, Paris J Aging (Albany NY). 2022; 14(13):5345-5365.

PMID: 35830469 PMC: 9320553. DOI: 10.18632/aging.204166.

SHBG, Bone Mineral Density, and Physical Function Among Injection Drug Users With and Without HIV and HCV.

Dias J, Piggott D, Sun J, Wehbeh L, Garza J, Abraham A J Clin Endocrinol Metab. 2022; 107(7):e2971-e2981.

PMID: 35293996 PMC: 9202730. DOI: 10.1210/clinem/dgac144.

References

Klein R, Lo Y, Santoro N, Dobs A . Androgen levels in older men who have or who are at risk of acquiring HIV infection. Clin Infect Dis. 2005; 41(12):1794-803. PMC: 2426822. DOI: 10.1086/498311. View

Blick G . Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels. Postgrad Med. 2013; 125(2):30-9. DOI: 10.3810/pgm.2013.03.2639. View

Waters L, Patterson B, Scourfield A, Hughes A, De Silva S, Gazzard B . A dedicated clinic for HIV-positive individuals over 50 years of age: a multidisciplinary experience. Int J STD AIDS. 2012; 23(8):546-52. DOI: 10.1258/ijsa.2012.011412. View

Dobs A, Few 3rd W, Blackman M, Harman S, Hoover D, Graham N . Serum hormones in men with human immunodeficiency virus-associated wasting. J Clin Endocrinol Metab. 1996; 81(11):4108-12. DOI: 10.1210/jcem.81.11.8923868. View

Martin M, Benassayag C, Amiel C, Canton P, Nunez E . Alterations in the concentrations and binding properties of sex steroid binding protein and corticosteroid-binding globulin in HIV+patients. J Endocrinol Invest. 1992; 15(8):597-603. DOI: 10.1007/BF03344932. View

Bhasin S, Cunningham G, Hayes F, Matsumoto A, Snyder P, Swerdloff R . Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010; 95(6):2536-59. DOI: 10.1210/jc.2009-2354. View

Mylonakis E, Koutkia P, Grinspoon S . Diagnosis and treatment of androgen deficiency in human immunodeficiency virus-infected men and women. Clin Infect Dis. 2001; 33(6):857-64. DOI: 10.1086/322695. View

Vermeulen A, Verdonck L, Kaufman J . A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999; 84(10):3666-72. DOI: 10.1210/jcem.84.10.6079. View

Bhasin S, Pencina M, Jasuja G, Travison T, Coviello A, Orwoll E . Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham Heart Study and applied to three geographically distinct cohorts. J Clin Endocrinol Metab. 2011; 96(8):2430-9. PMC: 3146796. DOI: 10.1210/jc.2010-3012. View

10.

Wunder D, Bersinger N, Fux C, Mueller N, Hirschel B, Cavassini M . Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy. Antivir Ther. 2007; 12(2):261-5. View

11.

Crum-Cianflone N, Bavaro M, Hale B, Amling C, Truett A, Brandt C . Erectile dysfunction and hypogonadism among men with HIV. AIDS Patient Care STDS. 2007; 21(1):9-19. DOI: 10.1089/apc.2006.0071. View

12.

Grinspoon S . Androgen deficiency and HIV infection. Clin Infect Dis. 2005; 41(12):1804-5. DOI: 10.1086/498320. View

13.

Kingsley L, Cuervo-Rojas J, Munoz A, Palella F, Post W, Witt M . Subclinical coronary atherosclerosis, HIV infection and antiretroviral therapy: Multicenter AIDS Cohort Study. AIDS. 2008; 22(13):1589-99. PMC: 3633463. DOI: 10.1097/QAD.0b013e328306a6c5. View

14.

Grinspoon S, Corcoran C, Lee K, Burrows B, Hubbard J, Katznelson L . Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting. J Clin Endocrinol Metab. 1996; 81(11):4051-8. DOI: 10.1210/jcem.81.11.8923860. View

15.

Rietschel P, Corcoran C, Stanley T, Basgoz N, Klibanski A, Grinspoon S . Prevalence of hypogonadism among men with weight loss related to human immunodeficiency virus infection who were receiving highly active antiretroviral therapy. Clin Infect Dis. 2000; 31(5):1240-4. DOI: 10.1086/317457. View

16.

Monroe A, Dobs A, Xu X, Palella F, Kingsley L, Witt M . Sex hormones, insulin resistance, and diabetes mellitus among men with or at risk for HIV infection. J Acquir Immune Defic Syndr. 2011; 58(2):173-80. PMC: 3175332. DOI: 10.1097/QAI.0b013e3182278c09. View

17.

Bhasin S, Travison T, Storer T, Lakshman K, Kaushik M, Mazer N . Effect of testosterone supplementation with and without a dual 5α-reductase inhibitor on fat-free mass in men with suppressed testosterone production: a randomized controlled trial. JAMA. 2012; 307(9):931-9. PMC: 6035750. DOI: 10.1001/jama.2012.227. View

18.

Aberg J, Gallant J, Ghanem K, Emmanuel P, Zingman B, Horberg M . Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine association of the Infectious Diseases Society of America. Clin Infect Dis. 2013; 58(1):e1-34. DOI: 10.1093/cid/cit665. View